Technical Analysis for JAGX - Jaguar Animal Health, Inc.

Grade Last Price % Change Price Change
grade F 1.73 -9.90% -0.19
JAGX closed down 9.9 percent on Tuesday, July 23, 2019, on 1.19 times normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical JAGX trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
New 52 Week Low Weakness 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish -9.90%
Narrow Range Bar Range Contraction -9.90%
NR7 Range Contraction -9.90%
Wide Bands Range Expansion -9.90%

Older signals for JAGX ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Jaguar Animal Health, Inc., a development-stage animal health company, focuses on developing and commercializing gastrointestinal products for companion and production animals. The company's lead prescription drug product candidate includes Canalevia, a canine-specific formulation of Crofelemer for the treatment of CID and general acute watery diarrhea in dogs. It is also developing Crofelemer to treat acute colitis in horses and general acute watery diarrhea in cats; Neonorm, an enteric-coated tablet for scours in preweaned dairy calves, as well as other animal species, such as horses, goats, and sheep; and other product candidates, including Virend and NP-500. The company was founded in 2013 and is headquartered in San Francisco, California. Jaguar Animal Health, Inc. is a subsidiary of Napo Pharmaceuticals, Inc.
Medicine Medical Specialties Gastroenterology Diarrhea Salix Pharmaceuticals Gastrointestinal Products Gastrointestinal Tract
Is JAGX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 175.0
52 Week Low 1.55
Average Volume 532,134
200-Day Moving Average 18.4849
50-Day Moving Average 7.2864
20-Day Moving Average 3.5405
10-Day Moving Average 2.644
Average True Range 0.6917
ADX 17.38
+DI 24.5709
-DI 40.3789
Chandelier Exit (Long, 3 ATRs ) 3.1249
Chandelier Exit (Short, 3 ATRs ) 3.6251
Upper Bollinger Band 5.6248
Lower Bollinger Band 1.4562
Percent B (%b) 0.07
BandWidth 117.740432
MACD Line -1.4933
MACD Signal Line -1.5723
MACD Histogram 0.0791
Fundamentals Value
Market Cap 187.16 Million
Num Shares 108 Million
EPS -0.16
Price-to-Earnings (P/E) Ratio -11.09
Price-to-Sales 11.19
Price-to-Book 0.00
PEG Ratio -0.01
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.32
Resistance 3 (R3) 2.32 2.13 2.22
Resistance 2 (R2) 2.13 1.98 2.13 2.18
Resistance 1 (R1) 1.93 1.89 1.84 1.93 2.15
Pivot Point 1.74 1.74 1.69 1.74 1.74
Support 1 (S1) 1.54 1.59 1.45 1.54 1.31
Support 2 (S2) 1.35 1.50 1.35 1.28
Support 3 (S3) 1.15 1.35 1.24
Support 4 (S4) 1.15